amifampridine Tablets 10 mg

Dossier type
Dossier status
Under development
Country of origin
GMP approvals
Unavailable markets
Costa Rica
Manufacturer #1338

Manufacturer usually replies in 7 days


Amifampridine is used predominantly to treat a range of rare muscle diseases. its free base form has been in use to treat congenital myasthenic syndromes and Lambert–Eaton myasthenic syndrome (LEMS) on compassionate use programs since the 1990s. However, it was not recommended as a first line treatment for LEMS till 2006. Amifampridine is in some cases also used in the treatment of psoriasis.

Congenital myasthenic syndromes are treated using Amifampridine. Especially in those with depleted choline acetyltransferase, downstream kinase 7. It is also involved when defects causes "fast channel" behavior of the acetylcholine receptor. Amifampridine is sold under the Brand names Firdapse and Zenas.

Around 2000 doctors in Paris created a phosphate salt, further developed through a series of companies. Finally, in 2009, BioMarin Pharmaceutical got approval in EU under the trade name Firdapse. Later in 2012, Catalyst Pharmaceuticals bought licensed to sell in the US. As for 2018, It has been approved by the US FDA for treating adults with LEMS. The FDA granted the approval to Jacobus Pharmaceutical, which has the only other treatment approved for LEMS in adults.

Dosage and administration

Amifampridine is sold as tablets of 10mg strength. In the treatment of Lambert-Eaton Myasthenic Syndrome, the recommended adult dose is 15 to 30 mg, given every day in 3 to 5 divided doses initially. This dose may be increased by 5 mg per day with maximum daily dose not to exceed 80 mg. The cost of Amifampridine As of 2018, in Europe, Amifampridine phosphate cost $60,000 for a treatment lasting a full year. In the USA, consumers have to shell out an average retail price of $23,603 for a supply of 120 tablets. In the global ingredients market, high grade Amifampridine cost USD 25,000 for a kilogram.

How does Amifampridine Work?

As symptomatic treatment, Amifampridine increases acetylcholine concentrations at the neuromuscular junction. Its actions block presynaptic fast voltage-gated potassium channels, which results in prolongation of cell membrane depolarization and action potential. It also augments the amount if calcium being transported into the nerve endings, which enhances the exocytosis of acetylcholine-containing vesicles. Amifampridine actions also enhance impulse transmission at central, autonomic, and neuromuscular synapses. Amifampridine increases the strength in our muscles. It also increases potential amplitudes in complex muscles.

Finding Amifampridine Manufacturers and Suppliers:

The process of finding trusted Amifampridine manufacturers and Amifampridine suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Amifampridine. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.